ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Los Angeles, CA, USA:

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer (EndoMAP)

This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune check ...

Enrolling
Endometrial Cancer
Drug: Talazoparib
Drug: Bevacizumab

Phase 1, Phase 2

Alliance Foundation Trials

Duarte, California, United States and 20 other locations

fulvestrant in patients with PIK3CA-mutated ER-positive endometrioid endometrial cancers by estimating the objective response rate ...

Enrolling
Endometroid Endometrial Cancer
Drug: Fulvestrant injection
Drug: Alpelisib Pill

Phase 2

GOG Foundation

Duarte, California, United States and 10 other locations

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Active, not recruiting
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

Los Angeles, California, United States and 65 other locations

Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor...

Active, not recruiting
Endometrial Cancer
Lung Cancer
Drug: Pembrolizumab
Drug: RGX-104

Phase 1

Inspirna

Los Angeles, California, United States of America and 20 other locations

IMGN151-1001 is a Phase 1, first in human, open-label dose-escalation and expansion study in adult patients with recurrent endometrial cancer...

Enrolling
Endometrial Cancer
Fallopian Tube Cancer
Drug: IMGN151

Phase 1

ImmunoGen
ImmunoGen

Los Angeles, California, United States and 8 other locations

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Doxorubicin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Los Angeles, California, United States and 209 other locations

This phase II trial studies how well abemaciclib works in treating patients with ovarian or endometrial cancer that has an activati ...

Enrolling
Recurrent Endometrial Carcinoma
Recurrent Primary Peritoneal Carcinoma
Drug: Anastrozole
Drug: Letrozole

Phase 2

Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center

Los Angeles, California, United States

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Tesaro
Tesaro

Newport Beach, California, United States and 162 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Doxorubicin
Drug: Paclitaxel

Phase 3

Eisai
Eisai

Santa Monica, California, United States and 168 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Beverly Hills, California, United States of America and 73 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems